Scandinavian Journal of Pain
Volume 1, Issue 1 , Page 5 , January 2010

Investigation of drug–drug interactions and pain—From volunteer studies to randomized controlled trials in patients with chronic pain

References 

  1. Ahonen J, Olkkola KT, Hynynen M, Salmenperä M, Neuvonen PJ. Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting. Anesthesiology. 1996;85:1246–1252
  2. Chyka PA. How many deaths occur annually from adverse drug reactions in the United States?. Am J Med. 2000;109:122–130
  3. Grönlund J, Hagelberg N, Saari TI, Laine K, Neuvonen PJ, Olkkola KT. Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone. J Clin Pharmacol; in press. http://dx.doi.org/10.1177/0091270009336444.
  4. Hagelberg N, Nieminen T, Saari TI, Laine K, Neuvonen PJ, Olkkola KT. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of oxycodone. Eur J Clin Pharmacol. 2009;65:263–271
  5. Heiskanen T, Olkkola KT, Kalso E. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacol Ther. 1998;64:603–611
  6. Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther. 2006;79:461–479
  7. Lemberg K, Heiskanen T, Neuvonen M, Kontinen VK, Neuvonen PJ, Dahl ML, et al. Does co-administration of paroxetine change oxycodone analgesia: an interaction study in chronic pain patients. Scand J Pain. 2010;2:24–33
  8. Nieminen TH, Hagelberg NM, Saari TI, Pertovaara A, Neuvonen M, Laine K, et al. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone. Anesthesiology. 2009;110:1371–1378
  9. Olkkola KT, Backman J, Neuvonen PJ. Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther. 1994;55:481–485
  10. Palkama VJ, Isohanni MH, Neuvonen PJ, Olkkola KT. The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil. Anesth Analg. 1998;87:190–194
  11. Pirmohamed M, James S, Meakin S, Green , Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329:15–19
  12. Varhe A, Olkkola KT, Neuvonen PJ. Effect of fluconazole dose on the extent of fluconazole–triazolam interaction. Br J Clin Pharmacol. 1996;42:465–470

PII: S1877-8860(09)00003-2

doi: 10.1016/j.sjpain.2009.09.002

Scandinavian Journal of Pain
Volume 1, Issue 1 , Page 5 , January 2010

Article Tools